{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT07328178",
      "orgStudyIdInfo": {
        "id": "S69940"
      },
      "organization": {
        "fullName": "KU Leuven",
        "class": "OTHER"
      },
      "briefTitle": "Analysis of the Role of IgE Proteoforms in Health and Disease",
      "officialTitle": "Analysis of the Role of IgE Proteoforms in Health and Disease",
      "acronym": "IgE-PhD"
    },
    "statusModule": {
      "statusVerifiedDate": "2025-11",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2025-01-01",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2029-01-01",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2029-01-01",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2025-12-26",
      "studyFirstSubmitQcDate": "2025-12-26",
      "studyFirstPostDateStruct": {
        "date": "2026-01-09",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2025-12-26",
      "lastUpdatePostDateStruct": {
        "date": "2026-01-09",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Rik Schrijvers",
        "investigatorTitle": "Prof. Dr. Rik Schrijvers",
        "investigatorAffiliation": "Universitaire Ziekenhuizen KU Leuven"
      },
      "leadSponsor": {
        "name": "KU Leuven",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of anaphylaxis, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), and patients undergoing desensitization for venom or medication allergy."
    },
    "conditionsModule": {
      "conditions": [
        "Anaphylaxis",
        "Mastocytosis",
        "X-linked Agammaglobulinaemia",
        "Venom Allergy",
        "Chronic Spontaneous Urticaria (CSU)",
        "Type I Allergy",
        "Medication Allergy",
        "Healthy Control",
        "Hereditary Alpha-Tryptasemia"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": false,
      "designInfo": {
        "observationalModel": "COHORT",
        "timePerspective": "PROSPECTIVE"
      },
      "bioSpec": {
        "retention": "SAMPLES_WITHOUT_DNA",
        "description": "Blood samples"
      },
      "enrollmentInfo": {
        "count": 200,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Healthy controls",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with type I allergy",
          "description": "Including medication allergy, venom allergy, food allergy, allergic rhinitis",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with chronic spontaneous urticaria",
          "description": "With or without omalizumab",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with a recent history of anaphylaxis",
          "description": "In whom serial sampling can be performed",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients undergoing desensitization for venom allergy",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients undergoing desensitization for medication allergy",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with mastocytosis",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with hereditary alpha tryptasemia",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        },
        {
          "label": "Patients with X-linked agammaglobulinemia (XLA)",
          "interventionNames": [
            "Other: Blood sample collection"
          ]
        }
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "Blood sample collection",
          "description": "Blood sample collection",
          "armGroupLabels": [
            "Healthy controls",
            "Patients undergoing desensitization for medication allergy",
            "Patients undergoing desensitization for venom allergy",
            "Patients with X-linked agammaglobulinemia (XLA)",
            "Patients with a recent history of anaphylaxis",
            "Patients with chronic spontaneous urticaria",
            "Patients with hereditary alpha tryptasemia",
            "Patients with mastocytosis",
            "Patients with type I allergy"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Evaluation of IgE proteoforms",
          "timeFrame": "4 years"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* CSU and type I allergic diseases (including anaphylaxis and desensitization), atopic dermatitis, mastocytosis, XLA and HaT (informed consent, age: any available adult subject, gender: any available subject, clinical phenotype and specific information about the allergy (e.g. severity, medication, medical history, laboratory testing)\n* Healthy controls (informed consent, age matched to the allergic patients, gender matched to the allergic patients, patient-reported symptoms related to allergy to aeroallergens, food, drugs, hymenoptera venom, CSU)\n\nExclusion Criteria:\n\n* Absence of informed consent\n* Age \\< 18 years old",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ],
      "studyPopulation": "Patients with type I allergy (including medication allergy, venom allergy, food allergy, allergic rhinitis), patients with chronic spontaneous urticaria (with or without omalizumab), patients with a recent history of anaphylaxis in whom serial sampling can be performed, patients undergoing desensitization for venom allergy, patients undergoing desensitization for medication allergy, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), healthy controls",
      "samplingMethod": "NON_PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Rik Schrijvers, MD, PhD",
          "affiliation": "UZ/KU Leuven",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "UZ/KU Leuven",
          "status": "RECRUITING",
          "city": "Leuven",
          "state": "Vlaams-Brabant",
          "zip": "3000",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Rik Schrijvers, MD, PhD",
              "role": "CONTACT",
              "phone": "016342985",
              "email": "rik.schrijvers@uzleuven.be"
            },
            {
              "name": "Dries Wets, MD",
              "role": "CONTACT",
              "phone": "016338198",
              "email": "dries.wets@kuleuven.be"
            },
            {
              "name": "Rik Schrijvers, MD, PhD",
              "role": "PRINCIPAL_INVESTIGATOR"
            },
            {
              "name": "Paul Proost, PhD",
              "role": "SUB_INVESTIGATOR"
            },
            {
              "name": "Frans Glynis, PharmD, PhD,",
              "role": "SUB_INVESTIGATOR"
            },
            {
              "name": "Christine Breynaert, MD, PhD",
              "role": "SUB_INVESTIGATOR"
            },
            {
              "name": "Dries Wets, MD",
              "role": "SUB_INVESTIGATOR"
            },
            {
              "name": "Rafaela Vaz Pereira, PhD",
              "role": "SUB_INVESTIGATOR"
            },
            {
              "name": "Toon Ieven, MD, PhD",
              "role": "SUB_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D000707",
          "term": "Anaphylaxis"
        },
        {
          "id": "D008415",
          "term": "Mastocytosis"
        },
        {
          "id": "C537409",
          "term": "Bruton type agammaglobulinemia"
        },
        {
          "id": "D000092422",
          "term": "Venom Hypersensitivity"
        },
        {
          "id": "D000080223",
          "term": "Chronic Urticaria"
        },
        {
          "id": "D004342",
          "term": "Drug Hypersensitivity"
        },
        {
          "id": "C000715748",
          "term": "Hereditary alpha-tryptasemia syndrome"
        }
      ],
      "ancestors": [
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        },
        {
          "id": "D009372",
          "term": "Neoplasms, Connective Tissue"
        },
        {
          "id": "D018204",
          "term": "Neoplasms, Connective and Soft Tissue"
        },
        {
          "id": "D009370",
          "term": "Neoplasms by Histologic Type"
        },
        {
          "id": "D009369",
          "term": "Neoplasms"
        },
        {
          "id": "D000090362",
          "term": "Mast Cell Activation Disorders"
        },
        {
          "id": "D014581",
          "term": "Urticaria"
        },
        {
          "id": "D017445",
          "term": "Skin Diseases, Vascular"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D002908",
          "term": "Chronic Disease"
        },
        {
          "id": "D020969",
          "term": "Disease Attributes"
        },
        {
          "id": "D010335",
          "term": "Pathologic Processes"
        },
        {
          "id": "D013568",
          "term": "Pathological Conditions, Signs and Symptoms"
        },
        {
          "id": "D064420",
          "term": "Drug-Related Side Effects and Adverse Reactions"
        },
        {
          "id": "D064419",
          "term": "Chemically-Induced Disorders"
        }
      ]
    }
  },
  "hasResults": false
}